If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
15.70    0.20 (1.29%)
Bid:
15.50
Ask:
15.80
Spread: 0.30 (1.935%)
Market Cap: £125.84m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Directorate Change

30 Jun 2008 07:00

RNS Number : 7977X
Manpower Software PLC
30 June 2008
 



For immediate release

30 June 2008

Manpower Software plc ("the Company") announces new appointment to the Board of Directors

Manpower Software plc, the leading supplier of workforce optimisation software applications, announces it has appointed Allen Arthur Albert Swann to serve as Business Development Director and a member of the Board of Directors with immediate effect.

Mr Swann is 57 years of age. He first became associated with the Company during February 2006 whilst acting as Interim Sales Director.  Since May 2007, he has focussed on building a substantial presence in the UK Healthcare Market.

Mr Swann is also Non Executive Chairman of the Board of CopperEye Ltd, a privately funded UK software company majoring in the telco marketplace, and a Non Executive Director of Chordiant Software Inc, a US based software company, which provides CRM software platforms to the world's largest financial institutions.  Prior to these appointments he served as International President for Chordiant Software Inc, International President of Prime Response Inc and was a founder member of Oracle UK, where he served as Sales Director both direct and non-direct for 12 years.

Terry Osborne, Manpower Software plc's Chairman, commented: "We are both fortunate and delighted that Allen, with his 25 years experience of the global software industry, will join us to provide strong business development leadership and execution skills at this critical stage in the Company's development.  His multi-national, multi-disciplined management abilities will be invaluable as the Company builds its sales and services capabilities to create profitable operations across multiple sectors and continents."

Allen Swann commented: "I am very pleased to be offered this opportunity to join the Board of Directors My association with the Company over the past 2.5 years has highlighted how important a role Manpower Software plc is playing in helping the UK Healthcare market more effectively utilise its staff, reduce costs, improve patient care and improve working lives.  There is an immense opportunity for the Company to continue to make a difference."

Details of Mr Swann's current and previous directorships in the past five years are set out below. 

Current directorships: Previous directorships:

UK:

CopperEye Ltd None

Overseas:

Chordiant Software Inc Solid Information Technology Inc

Mr Swann beneficially holds 1,119,000 Ordinary Shares, representing 2.5% of the Company's issued share capital.

In addition to the above, Mr Swann holds the following share options:

Scheme

Date of Grant

Number of options

Exercise price

Exercisable period

Unapproved Scheme

27.03.06

25,000

25.5p

27.03.09 - 26.03.16

Unapproved Scheme

9.10.06

225,000

18.5p

9.10.09 - 8.10.16

Total options held

250,000

There is no further information in connection with the appointment of Mr Allen Swann to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies

 

Enquiries:

Manpower Software plc

Ian Bowles CEO 020 7389 9500

Numis Securities Limited

Michael Meade 020 7260 1000James BlackBrent Nabbs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABRGDLCGDGGIR
Date   Source Headline
3rd Mar 20091:49 pmRNSAward of Contracts
4th Feb 20091:25 pmRNSHolding(s) in Company
21st Jan 20097:00 amRNSInterim Results
15th Jan 200911:58 amRNSHolding(s) in Company
19th Dec 200810:58 amRNSResult of AGM
10th Dec 20087:00 amRNSAcquisition of Baum Hart & Partners
1st Dec 20087:00 amRNSAward of Contracts
21st Nov 20084:32 pmRNSAnnual Report and Accounts
28th Oct 20087:00 amRNSHolding(s) in Company
1st Oct 20086:16 pmRNSHolding(s) in Company
1st Oct 20083:10 pmRNSHolding(s) in Company
17th Sep 20084:32 pmRNSHolding(s) in Company
10th Sep 20083:44 pmRNSHolding(s) in Company
8th Sep 20087:00 amRNSAward of contracts
28th Jul 20087:00 amRNSFinal Results
15th Jul 20085:43 pmRNSHolding(s) in Company
30th Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAward of Contract
2nd Jun 20087:00 amRNSAward of Contracts
27th May 20089:34 amRNSDirector/PDMR Shareholding
22nd May 20087:00 amRNSAward of Contract
6th May 20087:02 amRNSAward of Directors' Options
2nd May 20087:00 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSAcquisition
4th Apr 20087:01 amRNSTrading Statement
26th Mar 20088:00 amRNSAward of Contract
17th Mar 20087:00 amRNSAward of Contract
10th Mar 20087:00 amRNSAward of Contract
4th Mar 20087:00 amRNSAward of Contract
28th Feb 20089:01 amRNSExercise of Share Options
26th Feb 20087:00 amRNSAward of Contract
21st Feb 20087:00 amRNSAward of Contract
6th Feb 20087:01 amRNSInterim Results
4th Feb 20087:01 amRNSAward of Contract
31st Jan 20087:00 amRNSAward of Contract
22nd Jan 20087:00 amRNSAward of Contract
18th Jan 20087:01 amRNSAward of Contract
17th Jan 20087:00 amRNSHolding(s) in Company
15th Jan 200812:06 pmRNSHolding(s) in Company
4th Jan 20089:38 amRNSTotal Voting Rights
4th Jan 20087:00 amRNSAward of Contract
4th Jan 20087:00 amRNSAward of Contract
3rd Jan 20088:46 amRNSAward of Contract
20th Dec 20077:01 amRNSAGM Statement
12th Dec 200711:13 amRNSHolding(s) in Company
11th Dec 20077:00 amRNSCorrection: Holdings in Co.
10th Dec 20074:43 pmRNSHolding(s) in Company
3rd Dec 200711:30 amRNSDirector/PDMR Shareholding
29th Nov 20077:01 amRNSCirc re. contract extension
21st Nov 20077:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.